News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Updates in Frontline Treatment of Metastatic Liver Cancer

EP. 1: Overview and Diagnosis of HCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 2: Initiation of Systemic Therapy for mHCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 3: IMbrave150 Trial: Frontline Treatment of Advanced HCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 4: Safety of PD-L1 Inhibitors in mHCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 5: Role of VEGF TKIs for Treatment of HCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 6: ASCO 2020: HIMALAYA Trial for Advanced HCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 7: ASCO 2020 Data for Treatment of Advanced HCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 8: mHCC: Influence of PD-L1 Inhibitors on Second-Line Therapy

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

EP. 9: Future Directions for mHCC

ByRichard S. Finn, MD, UCLA Health,Richard Kim, MD, Moffitt Cancer Center,Riad Salem, MD, Northwestern University Feinberg School of Medicine,Amit Singal, MD, UT Southwestern Medical Center

July 24th 2020

Trending on OncLive

FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC

HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts

Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC

SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma

Five Under 5: Top Oncology Videos for the Week of 1/25